Stability melphalan solutions during preparation and storageBOSANQUET, A. G.Journal of pharmaceutical sciences. 1985, Vol 74, Num 3, pp 348-351, issn 0022-3549Article

Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidantsPERKOVIC, I; BUTULA, I; KRALJ, M et al.European journal of medicinal chemistry. 2012, Vol 51, pp 227-238, issn 0223-5234, 12 p.Article

Le traitement médical du mésothéliome pleural diffus: à propos d'un essai de chimiothérapie par vindesine chez 22 malades = Medical treatment of diffuse pleural mesothelioma: a trial of chemotherapy by vindesine in 22 patientsBOUTIN, C; IRISSON, M; GUERIN, J. C et al.Revue française des maladies respiratoires. 1983, Vol 11, Num 6, issn 0301-0279, 939Article

Antioxidant, antimicrobial and cytotoxic activities of selected medicinal plants from YemenAL-FATIMI, Mohamed; WURSTER, Martina; SCHRÖDER, Gudrun et al.Journal of ethnopharmacology. 2007, Vol 111, Num 3, pp 657-666, issn 0378-8741, 10 p.Article

Formulation, quality control and shelf life of the experimental cytostatic drug cyclopentenyl cytosineSCHIMMEL, Kirsten; GUCHELAAR, Henk-Jan; VAN KAN, Erik et al.Drug development and industrial pharmacy. 2006, Vol 32, Num 4, pp 497-503, issn 0363-9045, 7 p.Article

Synthesis and in vitro antiproliferative activity of new 1,3-(Oxytetraethylenoxy ) -cyclotriphosphazene derivativesSIWY, Mariola; SEK, Danuta; KACZMARCZYK, Bozena et al.Anticancer research. 2007, Vol 27, Num 3B, pp 1553-1558, issn 0250-7005, 6 p.Article

Objective assessment of tumour response to therapy based on tumour growth kineticsMEHRARA, E; FORSSELL-ARONSSON, E; BERNHARDT, P et al.British journal of cancer. 2011, Vol 105, Num 5, pp 682-686, issn 0007-0920, 5 p.Article

Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophagesNAKAHASHI, H; YASUMOTO, K; NAGASHIMA, A et al.Cancer research (Baltimore). 1984, Vol 44, Num 12, pp 5906-5909, issn 0008-5472, 1Article

De nouveaux cytostatiques par voie oraleLONGUEVILLE, J.Louvain médical. 2005, Vol 124, Num 8, pp 345-347, issn 0024-6956, 3 p.Article

Clavines: new antibiotics with cytostatic activityEICH, E; EICHBERG, D; MÜLLER, W. E. G et al.Biochemical pharmacology. 1984, Vol 33, Num 4, pp 523-526, issn 0006-2952Article

SPLENIC EMBOLIZATION TO PROVENT DOSE LIMITATION OF CANCER CHEMOTHERAPY = L'EMBOLISATION DE LA RATE POUR EVITER LA DIMINUTION DE LA DOSE EN CHIMIOTHERAPIE ANTICANCEREUSELOKICH J; COSTELLO P.1983; AMERICAN JOURNAL OF ROENTGENOLOGY; ISSN 0092-5381; USA; DA. 1983; VOL. 140; NO 1; PP. 159-161; BIBL. 7 REF.; GRAPH, FIGArticle

GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexateLEURS, Ulrike; LAJKO, Eszter; MEZO, Gabor et al.European journal of medicinal chemistry. 2012, Vol 52, pp 173-183, issn 0223-5234, 11 p.Article

Biopharmazie der Urologika = Biopharmacie des médicaments pour un traitement en urologie = Biopharmacy of drugs for urological treatmentFICKWEILER, E.Pharmazie. 1988, Vol 43, Num 2, pp 148-150, issn 0031-7144Article

Cytotoxic agents for use in dermatology. IMCDONALD, C. J.Journal of the American Academy of Dermatology. 1985, Vol 12, Num 5, pp 753-775, issn 0190-9622, part 1Article

Cytolytic activities of benfluron metabolites and loss of transplantabilityMIKO, M; KREPELKA, J; MELKA, M et al.International journal of tissue reactions. 1989, Vol 11, Num 3, pp 143-151, issn 0250-0868, 9 p.Article

Optimized Evolution in the Cytostat : A Monte Carlo SimulationGILBERT, Alan; SRIENC, Friedrich.Biotechnology and bioengineering. 2009, Vol 102, Num 1, pp 221-231, issn 0006-3592, 11 p.Article

Reciprocal biological activities of the cyclic tetrapeptides chlamydocin and HC-toxinWALTON, J. D; EARLE, E. D; STAHELIN, H et al.Experientia. 1985, Vol 41, Num 3, pp 348-350, issn 0014-4754Article

Activité cytostatique de Viscum cruciatum Sieber sur des cultures cellulaires. Toxicité aiguë = Cytostatic activity of Viscum cruciatum Sieber on cellular cultures. Acute toxicityAYUSO, M. J; DE MIGUEL, C; SAENZ, M. T et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 5, pp 459-461, issn 0003-4509Article

Antiémétiques au cours des traitements cytotoxiques = Antiemetic during cytolytic treatmentsPOUILLART, P.La Revue du praticien (Paris). 1993, Vol 43, Num 8, pp 1001-1006, issn 0035-2640Article

Chromosome abnormalities after cytostatic therapy, and distribution of fragile sites in peripheral blood lymphocytes of a breast cancer patientYAKOVLEVA, T. K; MONAKHOV, A. S; MOISEYENKO, V. M et al.Citologiâ. 1992, Vol 34, Num 2, pp 77-83, issn 0041-3771Article

Etude de quelques algues rouges des côtes sénégalaisesCOMBAUT, G; PIOVETTI, L; KORNPROBST, J.-M et al.Comptes-rendus des séances de l'Académie des sciences. Série 2, Mécanique-physique, chimie, sciences de l'univers, sciences de la terre. 1984, Vol 299, Num 8, pp 433-435, issn 0750-7623Article

CYTOSTATIC ACTIVITY OF SOME CANARY ISLANDS SPECIES OF RUTACEAE.GONZALEZ AG; DARIAS V; ALONSO G et al.1977; PLANTA MED.; ALLEM.; DA. 1977; VOL. 31; NO 4; PP. 351-356; BIBL. 15 REF.Article

Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cellsRUSSELL, E. G; O'SULLIVAN, E. C; MILLER, C. M et al.Investigational new drugs. 2014, Vol 32, Num 6, pp 1113-1122, issn 0167-6997, 10 p.Article

Synthesis, cytostatic activity and ADME properties of C-5 substituted and N-acyclic pyrimidine derivativesGAZIVODA KRALJEVIC, Tatjana; KLIKA, Mateja; KRALJ, Marijeta et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 308-312, issn 0960-894X, 5 p.Article

Genotoxic effects of wastewater from an oncological wardFERK, Franziska; MISIK, Miroslav; PARZEFALL, Wolfram et al.Mutation research. Genetic toxicology and environmental mutagenesis (Print). 2009, Vol 672, Num 2, pp 69-75, issn 1383-5718, 7 p.Article